Mandragora and Umbilical erythema - from FDA reports
There is no Umbilical erythema reported by people who take Mandragora yet. This review analyzes which people have Umbilical erythema with Mandragora. It is created by eHealthMe based on reports from FDA, and is updated regularly.
What to expect?
You are not alone!
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Jan, 17, 2018
No report is found.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Subscribe to the study: get notified of updates to the study.
Do you have Umbilical erythema when taking Mandragora?
- Check symptoms - is umbilical erythema caused by a drug or a condition?
- Get alerts to symptoms - forecast your symptoms and get alerts
- Report the side effect - help people in need and in real time
- Ask a question - ask a question related to the study
- write a post - share your experience related to the study
- More tools...
Expand the study to include all drugs with the same ingredientsUmbilical erythema and drugs with ingredients of european mandrake.
Expand the study to include reports from both FDA and eHealthMeUmbilical erythema and Mandragora from FDA and eHealthMe reports
Mandragora has active ingredients of european mandrake. (latest outcomes from Mandragora 2 users)
Umbilical erythema (redness at umbilical site) has been reported by people with acute kidney failure, stenotrophomonas infection, respiratory tract infection, multiple sclerosis, diabetes (latest reports from 21 Umbilical erythema patients).